Log in
Email Address
Password
Forgot your password?
Not Registered?

Featured Tenants

 cfai

The Centre for Advanced Instrumentation at the NETPark Research Institute collaborates with observatories world-wide in the construction, commissioning and exploitation of innovative hi-tech instruments for optical and infrared astronomy. Key research areas are advanced spectroscopy, adaptive optics, applied optics, low light level detectors and precision engineering/metrology.

Click here to learn more about Centre for Advanced Instrumentation

Featured Opportunity
Provision of value innovation specialist support to SME members of NETPark Net

The aim of this contract is to provide individual and tailored support to members of NETPark Net.  This service is expected to be focused on unlocking innovation within the existing operations of the companies and using this discovered potential to increase turnover and profitability, and create jobs.  For further information click here

The deadline is 11th July 2008

Polls



CDEP logo

cddc   eu

'Bionic eyes' give hope to blind
Bookmark and Share Add This     email Email a Friend    print Printable version

'Bionic eyes' give hope to blind

2008-04-23
Newsfeed

Hope has been given to sufferers of a hereditary disease affecting the retina after the first UK operations were carried out to implant so-called "bionic eyes" into patients, it has been disclosed.

Hope has been given to sufferers of a hereditary disease affecting the retina after the first UK operations were carried out to implant so-called "bionic eyes" into patients, it has been disclosed.

Surgeons at Moorfields Eye Hospital carried out successful operations to implant an artificial retinal device into the eyes of two blind patients as part of a clinical study.

The trial aims to restore a basic level of useful vision, in the form of spots of light and shapes of light and dark, to people suffering severe blindness due to retinitis pigmentosa (RP), a group of inherited eye diseases that affects the retina.

The operations were carried out by consultant retinal surgeon Lyndon da Cruz and his team at Moorfields in London, under the supervision of US colleagues who developed the device with the company Second Sight in the US.

Mr da Cruz said: "It is very special to be part of a programme developing a totally new type of treatment for patients who would otherwise have no chance of visual improvement."

British Retinitis Pigmentosa Society (BRPS) chief executive, David Head, said: "These are significant advances and it makes for really exciting times."

Copyright © The Press Association 2008


Add Comment | View All Comments (0)


Related Links